Please provide your email address to receive an email when new articles are posted on . Complications from the use of punctum plugs to treat aqueous insufficiency are fairly uncommon; however, adverse ...

Please provide your email address to receive an email when new articles are posted on . Punctal plugs are criticized by some due to their possible connection to granulomas and dacryocystitis. For this ...

Two-month sustained release drug may improve therapy over topical drop administration. BEDFORD, Mass., Aug. 21, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost ...

A retrospective administrative claims analysis of treatment options for dry eye disease (DED) evaluated treatment patterns and utilization characteristics of patients receiving cyclosporine, punctal ...

Completion of Facility Enables Initiation of Phase 3 Clinical Trial of Nepafenac in Patients Undergoing Cataract Surgery AUSTIN, Texas, Sept. 12, 2023 /PRNewswire/ -- Mati Therapeutics Inc. ("Mati") ...

Allogeneic haematopoietic SCT is performed for the treatment of many diseases. One of the major success-limiting factors after transplantation is the development of GvHD, which may lead to severe ...

The first tear duct implant developed to treat inflammation and pain following cataract surgery has been shown to be a reliable alternative to medicated eye drops, which are the current standard of ...

CHICAGO — A tapered-release dexamethasone punctum plug appears to be a reasonable alternative to medicated eye drops for patients who have undergone cataract surgery, according to early research. "In ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: I’m a 65-year-old female, non-smoker, with very dry eyes ...

BEDFORD, Mass., Aug. 20, 2012 /PRNewswire/ -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug feasibility study, the company is now entering a pilot Phase II clinical ...

Two-month sustained release drug may improve therapy over topical drop administration. BEDFORD, Mass., Aug. 20, 2012 -- Following encouraging results from Ocular Therapeutix's travoprost punctum plug ...